Imatinib Active Not Recruiting Phase 2 Trials for Transplantation, Stem Cell / Treatments Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01025505Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study